| Factor Information | |
|---|---|
| Data ID | 1554 |
| Factor | plasma P-selectin concentration |
| Description | plasma P-selectin concentration in PAH-CHD patients (18.97±0.93 ng/ml) was significantly higher than that in CHD subjects (14.22±0.61 ng/ml). However, no plasma P-selectin difference was observed between CHD and control group. |
| Biomarker | NA |
| Classification | E2 (physiological factor - biochemical index) |
| Association | |
|---|---|
| Application | prognosis and risk assessment |
| Objective | Relationship between P-selectin gene polymorphism and PAH-CHD |
| p Value | 0.0003 |
| Conclusion | Plasma P-selectin concentration in PAH-CHD patients was significantly higher than that in CHD subjects . However, no plasma P-selectin difference was observed between CHD and control group. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 539 |
| CHD Type | isolated CHD |
| CHD Subtype | ASD/PDA/VSD |
| Reference | |
|---|---|
| PMID | 26261613 |
| Year | 2015 |
| Title | P-selectin gene polymorphism associates with pulmonary hypertension in congenital heart disease. |
| Sample | ||
|---|---|---|
| Population | adolescents and adults | |
| Source | blood | |
| Region | Nantong, China | |
| Method | case-control correlation analysis | |
| Race | Asian | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | PAH-CHD patients(Treatment) | CHD patients(Control) |
| Number | 58 | 43 |
| Age | 31 (17.66) years | 32 (18.91) years |
| Gender (Male: Female) | 26:32 | 20:23 |
| Marker Level | 18.97±0.93 ng/ml | 14.22±0.61 ng/ml |
